A
$ Value
$0
Shares
27,081
Price
$0
Filed
Jun 3
Insider
Name
Compton-Phillips Amy
Title
EVP, Chief Medical Officer
CIK
0001741492
Roles
Officer
Transaction Details
Transaction Date
2025-05-31
Code
A
Table
Derivative
Ownership
Direct
Equity Swap
No
Shares After
27,081
Footnotes
Consists of restricted stock units awarded pursuant to Issuer's 2017 Incentive Compensation Plan. Restrictions lapse in three equal installments, commencing 5/31/2026. | Consists of restricted stock units awarded pursuant to Issuer's 2017 Incentive Compensation Plan. Restrictions lapse in four equal installments, commencing 5/31/2026. | Option becomes exercisable in four equal annual installments, commencing 5/31/2026.
Filing Info
Compton-Phillips Amy's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-03-31 | CVS | A | $400K |
| 2026-03-31 | CVS | A | $2.6M |
| 2025-05-31 | CVS | A | $3.0M |
| 2025-05-31 | CVS | A | $400K |
| 2025-05-31 | CVS | A | $0 |
Other Insiders at CVS (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
|
Nelson Steven H
EVP and President, Aetna
|
$1K | — | 2026-04-01 |
|
Joyner J. David
President, CEO and Chair
|
— | — | 2026-04-01 |
|
Khichi Samrat S.
EVP, CPO and General Counsel
|
— | — | 2026-04-01 |
|
CAPOZZI HEIDI B
EVP and Chief People Officer
|
— | — | 2026-04-01 |
|
Compton-Phillips Amy
EVP, Chief Medical Officer
|
— | — | 2026-03-31 |
|
Clark James David
SVP, Cont & Chief Acct Officer
|
— | — | 2026-04-01 |
|
Newman Brian
EVP, Chief Financial Officer
|
— | — | 2026-03-31 |
|
Mandadi Tilak
EVP, Chief Exp & Tech Officer
|
— | — | 2026-04-01 |
|
Shah Prem S
EVP and Group President
|
— | — | 2026-04-01 |